...
首页> 外文期刊>Surgery >The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.
【24h】

The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.

机译:术中甲状旁腺激素检测在肾移植后三级甲状旁腺功能亢进患者中的作用。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Intraoperative parathyroid hormone (PTH) testing has been shown to accurately define adequacy of parathyroid resection in patients with primary hyperparathyroidism (HPT) and alters the operative management in 10% to 15% of cases. However, the benefit of this technique in patients with tertiary HPT after renal transplantation undergoing parathyroidectomy is unclear. METHODS: Intraoperative PTH was measured in 32 consecutive patients undergoing parathyroidectomy for tertiary HPT after renal transplantation between March 2001 and November 2004 by using the Elecsys assay at baseline and, subsequently, 5, 10, and 15 minutes after curative resection. The outcomes of these patients were evaluated. RESULTS: All patients were cured after surgery. Of the 32 patients, 29 were found to have parathyroid hyperplasia, while 1 had a single adenoma and 2 had double adenomas. The average drop in intraoperative PTH levels after curative resection was 69 +/- 3.5% at 5 min., 77 +/- 2.3% at 10 minutes, and 83 +/- 3.4% at 15 minutes. PTH testing changed the intraoperative management in 5 (16%) patients. One patient with a single adenoma and 2 patients with double adenomas had a >50% drop at 10 minutes. after excision; therefore, the operation was terminated without further resection. Two patients did not have a >50% drop at 10 minutes after 3.5 gland resection. These patients were explored further, and additional supernumerary parathyroid glands were identified and resected. After resection of these additional glands, the PTH fell by >50%, indicating cure. CONCLUSIONS: In patients undergoing parathyroidectomy for tertiary HPT after renal transplantation, a decrease in intraoperative PTH levels >50% at 10 minutes after completion of the operation indicated adequate resection. Furthermore, intraoperative PTH testing altered the operative management in 16% of patients. Therefore, similar to its role in patients with primary HPT, intraoperative PTH testing appears to play an equally important role in the management of patients with tertiary HPT undergoing parathyroidectomy.
机译:背景:术中甲状旁腺激素(PTH)测试已被证明可以准确定义原发性甲状旁腺功能亢进症(HPT)患者甲状旁腺切除术的适当性,并在10%至15%的病例中改变手术管理。但是,该技术在进行甲状旁腺切除术的肾脏移植后的第三次HPT患者中的益处尚不清楚。方法:2001年3月至2004年11月,在基线时以及随后的根治性切除术后5分钟,10分钟和15分钟,对连续32例接受肾移植术后进行甲状旁腺切除术的第三次HPT患者进行术中PTH的测量。对这些患者的结局进行了评估。结果:所有患者术后均治愈。在32例患者中,发现29例患有甲状旁腺增生,而1例患有单个腺瘤,2例患有双腺瘤。根治性切除后术中PTH水平的平均下降在5分钟时为69 +/- 3.5%,在10分钟时为77 +/- 2.3%,在15分钟时为83 +/- 3.4%。 PTH测试改变了5名(16%)患者的术中管理。一名患有单个腺瘤的患者和两名患有双腺瘤的患者在10分钟时的跌幅> 50%。切除后因此,手术被终止而无需进一步切除。两名患者在3.5个腺体切除后的10分钟内跌幅不超过50%。对这些患者进行了进一步探查,并发现并切除了多余的甲状旁腺。切除这些额外的腺体后,PTH下降了> 50%,表明已治愈。结论:在肾移植后进行甲状旁腺切除术进行第三次HPT的患者中,术中PTH水平在手术结束后10分钟降低> 50%,表明有足够的切除术。此外,术中PTH检测改变了16%的患者的手术管理。因此,术中PTH检测与其在原发性HPT患者中的作用相似,似乎在对接受甲状旁腺切除术的第三次HPT患者的治疗中起着同等重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号